2023-08-04 03:33:06 ET
- Skanska ( OTCPK:SKBSY ) has secured contract worth $215 million, about SEK 2.25 billion with Seagen to construct a 25,000 square meter biomanufacturing facility for the global biotechnology company.
- The facility will include manufacturing, storage, shipping, office, and café space in Everett, Washington, USA.
- The contract will be included in the U.S. order bookings for the third quarter, 2023.
- Construction is underway and completion is anticipated for Q4, 2024.
For further details see:
Skanska secures contract with Seagen to build facility in Washington for $215 million